This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Thomas L. Whitsett, MD; Steven G. Chrysant, MD; Bonnie Dillard, PA; Anthony W. Czerwinski, MD
University of Oklahoma College of Medicine and the Veterans Administration Hospital Oklahoma City

JAMA. 1976;235(25):2717-2718.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Warnings have repeatedly been raised regarding the possibility of rebound hypertension following the abrupt cessation of therapy with clonidine hydrochloride.^1-6 While reports have suggested this as a possibility, they have largely been little more than individual case reports with no pretreatment blood pressure observations for comparison with the values obtained after cessation of clonidine administration. To our knowledge, there have been no studies specifically designed to ascertain the possibility of rebound hypertension.

We have designed a study to specifically evaluate the possibility of rebound hypertension in patients who have been receiving clonidine for three days, and then again for four weeks. To date, 12 patients with a mild to moderate degree of essential hypertension have completed the protocol. The blood pressure findings thus far are summarized in the Table.

At this point, there has been no evidence of rebound hypertension after abrupt cessation of clonidine use. . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?